APA (7th ed.) Citation

Surmeli, H., Isik, D., Kinikoglu, O., Altintas, Y. E., Ozkerim, U., Oksuz, S., . . . Turan, N. (2025). Impact of Age and Menopausal Status on T-DM1 (Ado-Trastuzumab Emtansine) Treatment Outcomes in HER2-Positive Breast Cancer. Pharmaceuticals (14248247), 18(6), 931. https://doi.org/10.3390/ph18060931

Chicago Style (17th ed.) Citation

Surmeli, Heves, Deniz Isik, Oguzcan Kinikoglu, Yunus Emre Altintas, Ugur Ozkerim, Sıla Oksuz, Tugba Basoglu, Hatice Odabas, and Nedim Turan. "Impact of Age and Menopausal Status on T-DM1 (Ado-Trastuzumab Emtansine) Treatment Outcomes in HER2-Positive Breast Cancer." Pharmaceuticals (14248247) 18, no. 6 (2025): 931. https://doi.org/10.3390/ph18060931.

MLA (9th ed.) Citation

Surmeli, Heves, et al. "Impact of Age and Menopausal Status on T-DM1 (Ado-Trastuzumab Emtansine) Treatment Outcomes in HER2-Positive Breast Cancer." Pharmaceuticals (14248247), vol. 18, no. 6, 2025, p. 931, https://doi.org/10.3390/ph18060931.